- Corporate Officers - W
- Woiwode Thomas
Insider Trading History of Woiwode Thomas
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Woiwode Thomas since 2016.
This trader's CIK number is 1619294.
At the time of last reporting, Woiwode Thomas was the Director of Tempest Therapeutics, Inc.. (stock ticker symbol TPST).
Also see all insider trading activities at Tempest Therapeutics, Inc..
Note that in the past
Woiwode Thomas also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Audentes Therapeutics, Inc. (BOLD) by Woiwode Thomas
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | BOLD | 35,000 | $525,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Passage Bio, Inc. (PASG) by Woiwode Thomas
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | PASG | 450,000 | $8,100,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Tempest Therapeutics, Inc. (TPST) by Woiwode Thomas
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | TPST | 2,118,644 | $4,999,999 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Gritstone Bio, Inc. (GRTS) by Woiwode Thomas
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | GRTS | 1,347,709 | $5,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Aligos Therapeutics, Inc. (ALGS) by Woiwode Thomas
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | ALGS | 200,000 | $3,000,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Crispr Therapeutics Ag (CRSP) by Woiwode Thomas
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | CRSP | 0 | $0 | 543,021 | $27,753,305 | 0 | $0 |
| 2017 | CRSP | 0 | $0 | 4,959 | $100,475 | 0 | $0 |
| 2016 | CRSP | 161,000 | $2,254,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 6 companies by Woiwode Thomas:
1. Audentes Therapeutics, Inc. (BOLD)
2. Passage Bio, Inc. (PASG)
3. Tempest Therapeutics, Inc. (TPST)
4. Gritstone Bio, Inc. (GRTS)
5. Aligos Therapeutics, Inc. (ALGS)
6. Crispr Therapeutics Ag (CRSP)
Table 1. Insider trading of Audentes Therapeutics, Inc. (BOLD) by Woiwode Thomas
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-07-25 | BOLD | Buy | 35,000 | 15.00 | 525,000 |
Table 2. Insider trading of Passage Bio, Inc. (PASG) by Woiwode Thomas
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-03-03 | PASG | Buy | 225,000 | 18.00 | 4,050,000 |
| 2020-03-03 | PASG | Buy | 225,000 | 18.00 | 4,050,000 |
Table 3. Insider trading of Tempest Therapeutics, Inc. (TPST) by Woiwode Thomas
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-04-29 | TPST | Buy | 2,118,644 | 2.36 | 4,999,999 |
Table 4. Insider trading of Gritstone Bio, Inc. (GRTS) by Woiwode Thomas
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-12-30 | GRTS | Buy | 1,347,709 | 3.71 | 5,000,000 |
Table 5. Insider trading of Aligos Therapeutics, Inc. (ALGS) by Woiwode Thomas
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-10-20 | ALGS | Buy | 200,000 | 15.00 | 3,000,000 |
Table 6. Insider trading of Crispr Therapeutics Ag (CRSP) by Woiwode Thomas
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-05-15 | CRSP | Sale | 44,000 | 58.35 | 2,567,400 |
| 2018-05-07 | CRSP | Sale | 119,709 | 50.78 | 6,079,421 |
| 2018-05-08 | CRSP | Sale | 1,653 | 51.45 | 85,046 |
| 2018-04-30 | CRSP | Sale | 30,566 | 50.28 | 1,536,950 |
| 2018-04-26 | CRSP | Sale | 210,610 | 50.12 | 10,554,720 |
| 2018-04-27 | CRSP | Sale | 11,648 | 50.03 | 582,807 |
| 2018-04-24 | CRSP | Sale | 22,841 | 50.90 | 1,162,606 |
| 2018-04-23 | CRSP | Sale | 101,994 | 50.83 | 5,184,355 |
| 2017-12-22 | CRSP | Sale | 3,059 | 20.29 | 62,070 |
| 2017-11-24 | CRSP | Sale | 1,700 | 20.21 | 34,358 |
| 2017-11-27 | CRSP | Sale | 200 | 20.24 | 4,047 |
| 2016-10-24 | CRSP | Buy | 161,000 | 14.00 | 2,254,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Woiwode Thomas
(Director of Tempest Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.